A new endoscopic technology for treating chronic bronchitis in patients in COPD has been shown to be feasible, well tolerated and safe in an international trial, including sites in Australia. And there were early signals for effectiveness in the first in-human study. Presented at the 2019 ERS Congress in Madrid, the RheOxTM bronchial rheoplasty uses ...
Already a member?
Enter your email to keep reading.